EP1430112A4 - Neue nukleinsäuren und polypeptide - Google Patents

Neue nukleinsäuren und polypeptide

Info

Publication number
EP1430112A4
EP1430112A4 EP02780359A EP02780359A EP1430112A4 EP 1430112 A4 EP1430112 A4 EP 1430112A4 EP 02780359 A EP02780359 A EP 02780359A EP 02780359 A EP02780359 A EP 02780359A EP 1430112 A4 EP1430112 A4 EP 1430112A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02780359A
Other languages
English (en)
French (fr)
Other versions
EP1430112A2 (de
Inventor
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1430112A2 publication Critical patent/EP1430112A2/de
Publication of EP1430112A4 publication Critical patent/EP1430112A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP02780359A 2001-09-24 2002-09-24 Neue nukleinsäuren und polypeptide Withdrawn EP1430112A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US324631P 2001-09-24
PCT/US2002/030474 WO2003029271A2 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1430112A2 EP1430112A2 (de) 2004-06-23
EP1430112A4 true EP1430112A4 (de) 2005-06-15

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02780359A Withdrawn EP1430112A4 (de) 2001-09-24 2002-09-24 Neue nukleinsäuren und polypeptide

Country Status (4)

Country Link
EP (1) EP1430112A4 (de)
AU (1) AU2002343417A1 (de)
CA (1) CA2461280A1 (de)
WO (1) WO2003029271A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311675B1 (de) 2000-08-22 2007-02-07 Agensys, Inc. Nukleinsäure und protein, genannt 158p1d7, für die behandlung und erkennung von blasenkrebs und anderen krebsarten
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6979564B2 (en) 2000-10-20 2005-12-27 Millennium Pharmaceuticals, Inc. 80090, human fucosyltransferase nucleic acid molecules and uses thereof
CA2443617C (en) * 2001-04-17 2013-12-10 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
FR2836687A1 (fr) 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
WO2004106495A2 (en) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
US20090253770A1 (en) * 2004-05-18 2009-10-08 Kurume University Target gene mimitin of myc
EP1811023A4 (de) 2004-09-29 2009-04-29 Dainippon Sumitomo Pharma Co Spezifisch in es-zellen exprimiertes gen und dessen nutzung
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
WO2008054534A2 (en) 2006-05-11 2008-05-08 Quark Pharmaceuticals, Inc. Screening systems utilizing rtp801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
EP1955705B1 (de) * 2007-02-09 2013-04-17 Gene Signal International Sa Wundheilender Wirkstoff und Zusammensetzung
EP1980254A1 (de) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Mittel und Verfahren zur Bekämpfung von Proteinaggregation
EP2178551A4 (de) * 2007-07-24 2010-07-21 Sanare Invest As Neuartige polypeptide mit antitumorwirkung
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (ja) * 2010-03-11 2013-05-23 Intec Systems Institute Inc 肺癌または子宮頸癌の診断マーカー
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
US20130210739A1 (en) * 2010-07-21 2013-08-15 Universite Pierre Et Marie Curie (Paris 6) Bhlh proteins and their use as drugs
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
TWI606063B (zh) 2012-08-23 2017-11-21 艾澤西公司 結合至１５８ｐ１ｄ７蛋白之抗體藥物結合物（ａｄｃ）
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
LT3388075T (lt) 2015-03-27 2023-11-10 Immatics Biotechnologies Gmbh Nauji peptidai ir peptidų deriniai, skirti naudoti imunoterapijai prieš įvairius navikus (seq id 25 - mrax5-003)
JP2024516542A (ja) * 2021-04-06 2024-04-16 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｍｈｃクラスｉペプチドを含む方法および組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002081629A2 (en) * 2001-04-03 2002-10-17 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002081629A2 (en) * 2001-04-03 2002-10-17 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 18 December 2001 (2001-12-18), "Novel human secreted protein #547.", XP002314713, retrieved from EBI accession no. GSP:AAU30056 Database accession no. AAU30056 *
DATABASE Geneseq [online] 5 February 2003 (2003-02-05), "Human protein NOV20a.", XP002314714, retrieved from EBI accession no. GSP:ABU11055 Database accession no. ABU11055 *
DATABASE UniProt [online] 1 June 2001 (2001-06-01), "Hemoglobin alpha 1 globin chain (Fragment).", XP002314712, retrieved from EBI accession no. UNIPROT:Q9BX83 Database accession no. Q9BX83 *
DATABASE USPTO Proteins [online] 10 December 1998 (1998-12-10), "Sequence 3 from patent US 5750345.", retrieved from EBI accession no. USPOP:AR007678 Database accession no. AR007678 *

Also Published As

Publication number Publication date
WO2003029271A3 (en) 2003-11-20
CA2461280A1 (en) 2003-04-10
AU2002343417A1 (en) 2003-04-14
EP1430112A2 (de) 2004-06-23
WO2003029271A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
EP1381621A4 (de) Neue nukleinsäuren und polypeptide
EP1470238A4 (de) Neue nukleinsäuren und polypeptide
EP1430112A4 (de) Neue nukleinsäuren und polypeptide
EP1490386A4 (de) Neuartige polypeptide sowie diese kodierende nukleinsäuren
EP1453967A4 (de) Bgl5-beta-glucosidase und diese codierende nukleinsäuren
ATE554171T1 (de) Rezeptor-nukleinsäuren und -polypeptide
EP1453968A4 (de) Bgl4-beta-glucosidase und diese codierende nukleinsäuren
EP1427746A4 (de) Systeme zur expression von proteinen und nukleinsäuren
CA2591841A1 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1472359A4 (de) Egvii-endoglucanase und diese codierende nukleinsäuren
EP1556490A4 (de) Neue nukleinsäuren und polypeptide
EP1294513A4 (de) Lokalisationsspezifische kovalente biokonjugation von proteinen
DE02784674T1 (de) Quantifizierung von polypeptiden
EP1357186A4 (de) Neue proteine und deren dnas
DK1330525T3 (da) NOD2-nukleinsyrer og proteiner
EP1695078A4 (de) Metadherin-polypeptide, codierende nukleinsäuren und verwendungsverfahren
EP1274716A4 (de) Neue nukleinsäuren und polypeptide
EP1499723A4 (de) Neue nukleinsäuren und polypeptide
EP1498486A4 (de) Nukleinsäurebibliothek und proteinbibliothek
EP1588140A4 (de) Mit krebs assoziierte nukleinsäuren und polypeptide
EP1488233A4 (de) Neue saure säugerproteine und diese codierende polynukleotide
EP1398376A4 (de) In neuroblastom isolierte nukleinsäuren
EP1506215A4 (de) Neue polypeptide mit sequenzähnlichkeit zu gdnfr und diese codierende nukleinsäuren
EP1457557A4 (de) Neue proteine und deren dnas
ATE512977T1 (de) Hcv-kernprotein-sequenzen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040322

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050503

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050818